PMC:7335697 / 82-455 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T2","span":{"begin":97,"end":102},"obj":"Body_part"},{"id":"T3","span":{"begin":319,"end":324},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma7197"},{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":"Objective\nKnowledge on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in liver transplant recipients is lacking, particularly in terms of severity of the disease. The aim of this study was to describe the demographic, baseline clinical characteristics and early outcomes of a European cohort of liver transplant recipients with SARS-CoV-2 infection."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T2","span":{"begin":97,"end":102},"obj":"Body_part"},{"id":"T3","span":{"begin":319,"end":324},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":"Objective\nKnowledge on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in liver transplant recipients is lacking, particularly in terms of severity of the disease. The aim of this study was to describe the demographic, baseline clinical characteristics and early outcomes of a European cohort of liver transplant recipients with SARS-CoV-2 infection."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T2","span":{"begin":23,"end":70},"obj":"Disease"},{"id":"T3","span":{"begin":23,"end":56},"obj":"Disease"},{"id":"T4","span":{"begin":72,"end":80},"obj":"Disease"},{"id":"T5","span":{"begin":84,"end":93},"obj":"Disease"},{"id":"T6","span":{"begin":352,"end":360},"obj":"Disease"},{"id":"T7","span":{"begin":363,"end":372},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Objective\nKnowledge on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in liver transplant recipients is lacking, particularly in terms of severity of the disease. The aim of this study was to describe the demographic, baseline clinical characteristics and early outcomes of a European cohort of liver transplant recipients with SARS-CoV-2 infection."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T3","span":{"begin":0,"end":9},"obj":"http://purl.obolibrary.org/obo/BFO_0000030"},{"id":"T4","span":{"begin":97,"end":102},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T5","span":{"begin":97,"end":102},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"},{"id":"T6","span":{"begin":191,"end":194},"obj":"http://purl.obolibrary.org/obo/PR_000001343"},{"id":"T7","span":{"begin":298,"end":299},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T8","span":{"begin":319,"end":324},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T9","span":{"begin":319,"end":324},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"}],"text":"Objective\nKnowledge on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in liver transplant recipients is lacking, particularly in terms of severity of the disease. The aim of this study was to describe the demographic, baseline clinical characteristics and early outcomes of a European cohort of liver transplant recipients with SARS-CoV-2 infection."}

{"project":"LitCovid-PubTator","denotations":[{"id":"6","span":{"begin":23,"end":70},"obj":"Species"},{"id":"7","span":{"begin":72,"end":82},"obj":"Species"},{"id":"8","span":{"begin":84,"end":93},"obj":"Disease"},{"id":"9","span":{"begin":352,"end":372},"obj":"Disease"}],"attributes":[{"id":"A6","pred":"tao:has_database_id","subj":"6","obj":"Tax:2697049"},{"id":"A7","pred":"tao:has_database_id","subj":"7","obj":"Tax:2697049"},{"id":"A8","pred":"tao:has_database_id","subj":"8","obj":"MESH:D007239"},{"id":"A9","pred":"tao:has_database_id","subj":"9","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Objective\nKnowledge on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in liver transplant recipients is lacking, particularly in terms of severity of the disease. The aim of this study was to describe the demographic, baseline clinical characteristics and early outcomes of a European cohort of liver transplant recipients with SARS-CoV-2 infection."}

{"project":"LitCovid-sentences","denotations":[{"id":"T3","span":{"begin":0,"end":9},"obj":"Sentence"},{"id":"T4","span":{"begin":10,"end":186},"obj":"Sentence"},{"id":"T5","span":{"begin":187,"end":373},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Objective\nKnowledge on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in liver transplant recipients is lacking, particularly in terms of severity of the disease. The aim of this study was to describe the demographic, baseline clinical characteristics and early outcomes of a European cohort of liver transplant recipients with SARS-CoV-2 infection."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T3","span":{"begin":23,"end":35},"obj":"SP_7"},{"id":"T4","span":{"begin":36,"end":47},"obj":"SP_7;UBERON:0001004"},{"id":"T5","span":{"begin":48,"end":70},"obj":"SP_7"},{"id":"T6","span":{"begin":72,"end":82},"obj":"SP_7"},{"id":"T7","span":{"begin":97,"end":102},"obj":"UBERON:0002107"},{"id":"T8","span":{"begin":319,"end":324},"obj":"UBERON:0002107"},{"id":"T9","span":{"begin":352,"end":362},"obj":"SP_7"},{"id":"T37655","span":{"begin":23,"end":35},"obj":"SP_7"},{"id":"T28710","span":{"begin":36,"end":47},"obj":"SP_7;UBERON:0001004"},{"id":"T24293","span":{"begin":48,"end":70},"obj":"SP_7"},{"id":"T12225","span":{"begin":72,"end":82},"obj":"SP_7"},{"id":"T11671","span":{"begin":97,"end":102},"obj":"UBERON:0002107"},{"id":"T23346","span":{"begin":319,"end":324},"obj":"UBERON:0002107"},{"id":"T7088","span":{"begin":352,"end":362},"obj":"SP_7"}],"text":"Objective\nKnowledge on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in liver transplant recipients is lacking, particularly in terms of severity of the disease. The aim of this study was to describe the demographic, baseline clinical characteristics and early outcomes of a European cohort of liver transplant recipients with SARS-CoV-2 infection."}